Inspire Investing’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$405K Buy
+4,544
New +$437K 0.02% 1022

Other funds holding SYRE

Inspire Investing's SYRE Position: Q3 2026 in Review

Inspire Investing opened a new position in Spyre Therapeutics (SYRE) in Q3 2026: 4,544 shares worth $405K. The stake represents 0.02% of the portfolio and ranks #1022 among its holdings.

286 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.

  • Inspire Investing held 4,544 shares of Spyre Therapeutics worth $405K as of Q3 2026.
  • Spyre Therapeutics was a new Inspire Investing position in Q3 2026.
  • Spyre Therapeutics made up 0.02% of Inspire Investing's portfolio in Q3 2026, its #1022 holding.
  • 286 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.